Opinion

Charlesbank puts Ensono on the block and Pamlico raises $1.4 billion for its fifth fund.

GPs waive carried interest on investments and Ares is back to market with a new debt fund.

In healthcare, private equity firms are buzzing around the primary care vertical.

Genstar buys RS Energy from Warburg Pincus and InTandem preps Cano Health for sale.

Butterfly makes a significant hire and American Pacific Group is raising its debut fund.

Pharmaceutical Product Development goes public eight years after H&F and Carlyle completed its buyout.

Edgewell Personal Care drops its bid to acquire Harry's after the FTC steps in to block it and a veteran CCMP healthcare exec leaves the firm after nearly 20 years.

Summit and Noro-Moseley may be selling MacStadium and Advent buys a software company that targets boutique fitness brands.

WCAS-backed Green Street Advisors inks a media deal and TPG explores a secondary single-asset transaction for Creative Artists Agency.

Good news for private equity and Bain's investment in Engineering Group brings the latter company's valuation to over 1.6 billion euros.